These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15716328)

  • 21. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
    Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
    Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGFbeta1 selectively up-regulates CCR1 expression in primary murine astrocytes.
    Han Y; Wang J; Zhou Z; Ransohoff RM
    Glia; 2000 Mar; 30(1):1-10. PubMed ID: 10696139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
    Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
    Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.
    Veillard NR; Kwak B; Pelli G; Mulhaupt F; James RW; Proudfoot AE; Mach F
    Circ Res; 2004 Feb; 94(2):253-61. PubMed ID: 14656931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chemokine receptor antagonist inhibits experimental breast tumor growth.
    Robinson SC; Scott KA; Wilson JL; Thompson RG; Proudfoot AE; Balkwill FR
    Cancer Res; 2003 Dec; 63(23):8360-5. PubMed ID: 14678997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.
    Eis V; Luckow B; Vielhauer V; Siveke JT; Linde Y; Segerer S; Perez De Lema G; Cohen CD; Kretzler M; Mack M; Horuk R; Murphy PM; Gao JL; Hudkins KL; Alpers CE; Gröne HJ; Schlöndorff D; Anders HJ
    J Am Soc Nephrol; 2004 Feb; 15(2):337-47. PubMed ID: 14747380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.
    Topham PS; Csizmadia V; Soler D; Hines D; Gerard CJ; Salant DJ; Hancock WW
    J Clin Invest; 1999 Dec; 104(11):1549-57. PubMed ID: 10587518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists.
    Anders HJ; Ninichuk V; Schlöndorff D
    Kidney Int; 2006 Jan; 69(1):29-32. PubMed ID: 16374420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
    Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
    Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis.
    Ryu M; Mulay SR; Miosge N; Gross O; Anders HJ
    J Pathol; 2012 Jan; 226(1):120-31. PubMed ID: 21953121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3.
    Elsner J; Dulkys Y; Gupta S; Escher SE; Forssmann WG; Kapp A; Forssmann U
    Allergy; 2005 Nov; 60(11):1386-93. PubMed ID: 16197470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases.
    Furuichi K; Wada T; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Kobayashi K; Takasawa K; Kida H; Takeda SI; Mukaida N; Matsushima K; Yokoyama H
    Am J Nephrol; 2000; 20(4):291-9. PubMed ID: 10970982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial CpG-DNA accelerates Alport glomerulosclerosis by inducing an M1 macrophage phenotype and tumor necrosis factor-α-mediated podocyte loss.
    Ryu M; Kulkarni OP; Radomska E; Miosge N; Gross O; Anders HJ
    Kidney Int; 2011 Jan; 79(2):189-98. PubMed ID: 20962742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas.
    Lu P; Nakamoto Y; Nemoto-Sasaki Y; Fujii C; Wang H; Hashii M; Ohmoto Y; Kaneko S; Kobayashi K; Mukaida N
    Am J Pathol; 2003 Apr; 162(4):1249-58. PubMed ID: 12651617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chemokine CCL5 is essential for leukocyte recruitment in a model of severe Herpes simplex encephalitis.
    Vilela MC; Mansur DS; Lacerda-Queiroz N; Rodrigues DH; Lima GK; Arantes RM; Kroon EG; da Silva Campos MA; Teixeira MM; Teixeira AL
    Ann N Y Acad Sci; 2009 Feb; 1153():256-63. PubMed ID: 19236348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
    Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
    Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface.
    Hannan NJ; Jones RL; White CA; Salamonsen LA
    Biol Reprod; 2006 May; 74(5):896-904. PubMed ID: 16452465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue.
    Reichel CA; Khandoga A; Anders HJ; Schlöndorff D; Luckow B; Krombach F
    J Leukoc Biol; 2006 Jan; 79(1):114-22. PubMed ID: 16275892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.